{"id":2042,"date":"2026-07-06T15:47:26","date_gmt":"2026-07-06T13:47:26","guid":{"rendered":"https:\/\/filiere-ia.fr\/projets\/longitudinal-follow-up-by-the-cancer-data-platform-of-patients-with-unresectable-stage-iii-nsclc-treated-with-durvalumab-following-chemoradiotherapy-within-the-framework-of-the-temporary-authorizat\/"},"modified":"2026-07-31T10:11:27","modified_gmt":"2026-07-31T08:11:27","slug":"longitudinal-follow-up-by-the-cancer-data-platform-of-patients-with-unresectable-stage-iii-nsclc-treated-with-durvalumab-following-chemoradiotherapy-within-the-framework-of-the-temporary-authorizat","status":"publish","type":"projets","link":"https:\/\/filiere-ia.fr\/en\/projets\/longitudinal-follow-up-by-the-cancer-data-platform-of-patients-with-unresectable-stage-iii-nsclc-treated-with-durvalumab-following-chemoradiotherapy-within-the-framework-of-the-temporary-authorizat\/","title":{"rendered":"Longitudinal follow-up of patients with inoperable stage III non-small cell lung cancer treated with durvalumab, via the National Cancer Institute\u2019s Cancer Data Platform"},"template":"","categorie_de_projet":[16],"class_list":["post-2042","projets","type-projets","status-publish","hentry","categorie_de_projet-lung-cancer"],"acf":[],"_links":{"self":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/projets\/2042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/projets"}],"about":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/types\/projets"}],"wp:attachment":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/media?parent=2042"}],"wp:term":[{"taxonomy":"categorie_de_projet","embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/categorie_de_projet?post=2042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}